Oncology
Refine Search
Pharmaceutical
Lilly takes another dip into radiopharma, via deal with Aktis Oncology 21 May 2024
Pharmaceutical
Foghorn Therapeutics has announced the pricing of a direct share offering, with the goal of raising $110 million. 21 May 2024
Pharmaceutical
Israeli dermatology company Sol-Gel Technologies has signed an agreement with Beimei Pharma for the commercialization of Twyneo (tretinoin/benzoyl peroxide) in 21 May 2024
Biotechnology
Pheon Therapeutics bags $120 million financing to fund ADC pipeline 21 May 2024
Biotechnology
FDA Breakthrough status for Roche’s inavolisib 21 May 2024
Pharmaceutical
While AstraZeneca’s chief executive Pascal Soriot has been proven right about many of his prior boasts on the company’s future success during his 12-year reign, 21 May 2024
Biotechnology
Australian radiopharma developer Telix Pharmaceuticals has filed for a secondary listing, with proposals for an initial public offering in the USA. 20 May 2024
Biotechnology
AstraZeneca set to spend $1.5 billion on ADCs production in Singapore 20 May 2024
Biotechnology
FDA withdraws accelerated approval for Truseltiq in cholangiocarcinoma 20 May 2024
Biotechnology
The week in pharma: action, reaction and insight – week to May 17, 2024 19 May 2024
Biotechnology
FDA rejects HLB’s rivoceranib liver cancer drug 18 May 2024
Biotechnology
Precision oncology company Erasca, which is focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, 17 May 2024
Pharmaceutical
Swiss cancer giant Novartis and German drugmaker Bayer are among the latest companies to lift the lid on upcoming data presentations at ASCO 2024. 17 May 2024
Biotechnology
Amgen gains early FDA approval for lung cancer drug Imdelltra 17 May 2024
Pharmaceutical
Japanese drugmaker Ono Pharmaceutical has received supplemental approvals for the BRAF inhibitor Braftovi (encorafenib), and the MEK inhibitor Mektovi (binimeti 17 May 2024
Pharmaceutical
Boston, USA-based start-up Monte Rosa Therapeutics intends to raise around $100 million through a public share offering. 17 May 2024
Biotechnology
FDA grants accelerated approval for BMS’ Breyanzi in FL 16 May 2024
Pharmaceutical
Lantheus names new execs to accelerate innovation 16 May 2024
Pharmaceutical
Shares in Merck KGaA rose by around 4% in Wednesday’s trading after the Germany-based company presented its first quarter financial results and latest forecast 15 May 2024
Pharmaceutical
More leading oncology companies have outlined their planned highlights for the upcoming annual meeting of the American Society of Clinical Oncology (ASCO). 15 May 2024
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze